Early phase clinical trials in India: Need & scope

被引:2
|
作者
Kshirsagar, Nilima Arun [1 ]
Pahuja, Monika [2 ]
Chatterjee, N. S. [2 ]
Kamboj, V. P. [3 ]
机构
[1] ICMR Natl Inst Res Reprod & Child Hlth, Natl Chair Clin Pharmacol, Mumbai 400012, Maharashtra, India
[2] Indian Council Med Res, Div Basic Med Sci, New Delhi 110029, India
[3] Cent Drug Res Inst, Dept Reprod Biol, Lucknow 226031, Uttar Pradesh, India
关键词
D O I
10.4103/ijmr.ijmr_1688_22
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [41] Participation of Hypertension Patients in Early-Phase Clinical Trials
    Borron, Paul
    Cohen, Oren
    Hoofwijk, Theo J.
    Turner, J. Rick
    JOURNAL OF CLINICAL HYPERTENSION, 2014, 16 (06): : 389 - 392
  • [42] Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
    Alfons Verbruggen
    Heinz H. Coenen
    Jean-Robert Deverre
    Denis Guilloteau
    Bengt Langstrom
    Piero A. Salvadori
    Christer Halldin
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 2144 - 2151
  • [43] TRENDS IN EARLY PHASE CARDIOLOGY CLINICAL TRIALS: BRIC NATIONS
    Patel, Akash P.
    Mohammad, Khan O.
    Seghers, Matthew
    Kothapalli, Priya
    Monteleone, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2294 - 2294
  • [44] Compliance in Early-Phase Cancer Clinical Trials Research
    Kurzrock, Razelle
    Stewart, David J.
    ONCOLOGIST, 2013, 18 (03): : 308 - 313
  • [45] Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU
    Verbruggen, Alfons
    Coenen, Heinz H.
    Deverre, Jean-Robert
    Guilloteau, Denis
    Langstrom, Bengt
    Salvadori, Piero A.
    Halldin, Christer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (11) : 2144 - 2151
  • [46] Combined criteria for dose optimisation in early phase clinical trials
    Alam, M. Iftakhar
    Coad, D. Stephen
    Bogacka, Barbara
    STATISTICS IN MEDICINE, 2019, 38 (21) : 4172 - 4188
  • [47] Early phase clinical trials to identify optimal dosing and safety
    Cook, Natalie
    Hansen, Aaron R.
    Siu, Lillian L.
    Razak, Albiruni R. Abdul
    MOLECULAR ONCOLOGY, 2015, 9 (05) : 997 - 1007
  • [48] EARLY TERMINATION OF PHASE-2 CLINICAL-TRIALS
    HERSON, J
    BIOMETRICS, 1978, 34 (01) : 157 - 158
  • [49] Experiences of establishing an academic early phase clinical trials unit
    Brown, Sarah R.
    Sherratt, Debbie
    Booth, Gill
    Brown, Julia
    Collinson, Fiona
    Gregory, Walter
    Flanagan, Louise
    CLINICAL TRIALS, 2017, 14 (04) : 349 - 356
  • [50] Starting clinical trials of xenotransplantation - reflections on the ethics of the early phase
    Welin, S
    JOURNAL OF MEDICAL ETHICS, 2000, 26 (04) : 231 - 236